# Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy

> **NCT03577782** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hospitales Universitarios Virgen del Rocío** · enrollment: 12 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Entyvio (Vedolizumab)

## Key facts

- **NCT ID:** NCT03577782
- **Lead sponsor:** Hospitales Universitarios Virgen del Rocío
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03577782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03577782, "Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03577782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*